
Nanosonics
Nanosonics is an Australian company specializing in infection control and decontamination technologies. It aims to be a global leader by providing economical and safe solutions that prevent the transmission of infections. The company focuses on research, development, and commercialization of innovative technologies in the healthcare sector.
Short position
Nanosonics (ASX:NAN) has 6.44% of its shares on issue reported as short positions as of 5 Oct 2026, or about 19,279,584 shares. Over the past 30 days that figure has fallen 0.70 percentage points, and over 90 days it has fallen 0.48 percentage points. Its highest recorded short interest was 14.09% in April 2018. NAN is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Nanosonics (NAN) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $203.9Mvs $198.9M (FY25)
- Yahoo Finance, as at 29 Sep 2026
- NPAT
- $17.8Mvs $20.7M (FY25)
- Yahoo Finance, as at 29 Sep 2026
- EPS (diluted)
- $0.058T (source: Derived: trailing 12 months at year end)vs $0.067 (FY25)
- Derived: trailing 12 months at year end, as at 29 Sep 2026
- Rev YoY
- +2.5%FY
- EPS YoY
- −13.8%TTM
- Derived: trailing 12 months at year end
Key ratios
Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 9 Oct 2026
- Gross margin
- 76.9%
- Operating margin
- 3.3%
- Net margin
- 8.7%
- FCF margin
- 8.5%
- ROE
- 8.3%
- ROA
- 6.2%
- FCF conversion
- 0.98×
- Net cash (excl. leases)
- $155.2M
- Net debt / EBITDA
- −5.1×
- Current ratio
- 5.6×
- Interest cover
- 4.0×
- Cash dividends paid / net profit
- n/a
- Market cap
- $848.9M
- P/E
- 49.2×
- P/B
- 3.9×
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 29 Sep 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $203.9M | $198.9M | $171.6M | $167.5M |
| Gross profit | $156.8M | $155.7M | $134.0M | $132.2M |
| Operating income | $6.7M | $8.9M | $754.0K | $10.9M |
| EBITDA | $30.5M | $31.8M | $21.7M | $29.5M |
| EBIT | $21.8M | $23.8M | $14.1M | $22.4M |
| Interest expense | $1.7M | $1.5M | $1.1M | $771.0K |
| Pretax income | $20.1M | $22.3M | $13.0M | $21.6M |
| Tax | $2.3M | $1.6M | $14.0K | $1.7M |
| NPAT | $17.8M | $20.7M | $13.0M | $19.9M |
| Net interest income | $4.1M | $4.5M | $3.9M | $2.0M |
| EPS basic | $0.059T (source: Derived: trailing 12 months at year end) | $0.068 | $0.043 | $0.066 |
| EPS diluted | $0.058T (source: Derived: trailing 12 months at year end) | $0.067 | $0.042 | $0.065 |
| Shares | 298.9M | 303.6M | 303.0M | 302.3M |
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- 2026 Full Year Financial ResultsFull Year Results25 Aug 2026via asx_announcements
- Appendix 4EAnnual Results25 Aug 2026via asx_announcements
- 2026 Annual ReportAnnual Report25 Aug 2026via asx_announcements
- FY26 Full Year Results webinar notificationFull Year Results7 Aug 2026via asx_announcements
- Appendix 4D and Half Year AccountsHalf Year Results24 Feb 2026via asx_announcements
- 2026 Half Year ResultsHalf Year Results24 Feb 2026via asx_announcements
- 2026 Half Year Financial Results Investor PresentationHalf Year Results24 Feb 2026via asx_announcements
- 2026 Half Year Results conference call notificationHalf Year Results27 Jan 2026via asx_announcements
- 2025 Half Year Results Investor PresentationFinancial Report31 Dec 2025via crawler
- 2025 Corporate Governance StatementFinancial Report31 Dec 2025via crawler
Showing 10 of 117 reports